MIM
ENOV icon

MetLife Investment Management’s Enovis ENOV Stock Holding History

MetLife Investment Management’s Portfolio ENOV Stock Details ENOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$725K Sell
31,858
-284
-0.9% -$6.71K ﹤0.01% 1569
2025
Q4 		$856K Sell
32,142
-1,965
-6% -$58.1K ﹤0.01% 1518
2025
Q3 		$1.03M Hold
34,107
– – 0.01% 1429
2025
Q2 		$1.07M Buy
34,107
+33,094
+3,267% +$1.09M 0.01% 1271
2025
Q1 		$38.7K Sell
1,013
-30,474
-97% -$1.29M ﹤0.01% 2713
2024
Q4 		$1.38M Buy
31,487
+2,648
+9% +$116K 0.01% 1256
2024
Q3 		$1.24M Buy
28,839
+2,476
+9% +$110K 0.01% 1265
2024
Q2 		$1.19M Sell
26,363
-983
-4% -$51K 0.01% 1252
2024
Q1 		$1.71M Sell
27,346
-719
-3% -$43K 0.01% 1033
2023
Q4 		$1.57M Sell
28,065
-432
-2% -$21.5K 0.01% 1063
2023
Q3 		$1.5M Sell
28,497
-331
-1% -$19.3K 0.01% 1032
2023
Q2 		$1.85M Sell
28,828
-452
-2% -$25.7K 0.01% 964
2023
Q1 		$1.57M Sell
29,280
-782
-3% -$45.3K 0.01% 1003
2022
Q4 		$1.61M Sell
30,062
-590
-2% -$30.4K 0.01% 994
2022
Q3 		$1.41M Buy
30,652
+7
+0% +$379 0.01% 1023
2022
Q2 		$1.69M Sell
30,645
-8,175
-21% -$527K 0.01% 958
2022
Q1 		$2.66M Buy
38,820
+905
+2% +$64.5K 0.02% 873
2021
Q4 		$3M Buy
37,915
+1,761
+5% +$147K 0.02% 682
2021
Q3 		$2.86M Buy
36,154
+1,906
+6% +$153K 0.03% 672
2021
Q2 		$2.7M Sell
34,248
-359
-1% -$27.5K 0.02% 734
2021
Q1 		$2.61M Buy
34,607
+2,595
+8% +$190K 0.02% 745
2020
Q4 		$2.11M Sell
32,012
-1,462
-4% -$85.4K 0.02% 799
2020
Q3 		$1.81M Buy
33,474
+4,488
+15% +$246K 0.02% 765
2020
Q2 		$1.39M Buy
28,986
+1,103
+4% +$48.7K 0.02% 882
2020
Q1 		$950K Hold
27,883
– – 0.01% 919
2019
Q4 		$1.75M Sell
27,883
-348
-1% -$19.7K 0.02% 858
2019
Q3 		$1.41M Sell
28,231
-4,546
-14% -$215K 0.02% 915
2019
Q2 		$1.58M Sell
32,777
-877
-3% -$42.2K 0.02% 913
2019
Q1 		$1.72M Buy
33,654
+33,587
+50,130% +$1.47M 0.02% 878
2018
Q4 		$2.4K Sell
67
-2
-3% -$93 ﹤0.01% 2533
2018
Q3 		$4.25K Buy
+69
New +$3.93K ﹤0.01% 2544

Other funds holding ENOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

MetLife Investment Management's ENOV Position: Q1 2026 in Review

MetLife Investment Management reduced its Enovis (ENOV) stake by 0.88% in Q1 2026, selling an estimated $6.71K and leaving 31,858 shares worth $725K. The position accounts for ﹤0.01% of the portfolio, ranked #1569.

MetLife Investment Management first reported a position in ENOV in Q3 2018 and has held it in 31 quarters since. The position peaked at $3M in Q4 2021. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • MetLife Investment Management held 31,858 shares of Enovis worth $725K as of Q1 2026.
  • MetLife Investment Management sold 284 Enovis shares in Q1 2026, an estimated $6.71K.
  • Enovis made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1569 holding.
  • MetLife Investment Management first reported a position in Enovis in Q3 2018 and has held it in 31 quarters since.
  • MetLife Investment Management's Enovis position peaked at $3M in Q4 2021.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.